FDA Inspection
AlloSourceAlloSource – FDA Inspection, Mar 30, 2023
Record Details
This FDA Inspection record concerns AlloSource, with an inspection on March 30, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 9feeb28f-e5dc-4eb3-8401-23c3664c6f22
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1201259
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.190(b)(1)Clean, sanitary, orderly manner
- 21 CFR 1271.230(a)Validation & approval--established procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AlloSource
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 28, 2026 | Not classified | Denver District Office | Human Cellular, Tissue, and Gene Therapies |
| July 27, 2022 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| December 18, 2018 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| February 9, 2017 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| June 11, 2015 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for AlloSource
- FDA Inspection 1333098 - 2026-08-28
- FDA Inspection 1175639 - 2022-07-27
- FDA Inspection 1074854 - 2018-12-18
- FDA Inspection 1010063 - 2017-02-09
- FDA Inspection 929703 - 2015-06-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.